Gentium S.p.A. announced today that, following its request for re-examination, the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion for Defitelio recommending a Marketing Authorization Application under exceptional circumstances, for the treatment of severe hepatic veno-occlusive disease in ... (more)
http://www.benzinga.com/news/13/07/3786684/gentium-receives-positive-opinion-from-emas-chmp-for-defitelio
http://www.benzinga.com/news/13/07/3786684/gentium-receives-positive-opinion-from-emas-chmp-for-defitelio
No comments:
Post a Comment